Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 9.0E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Bladder Wall 4.9E-09 2.5E-08 8.6E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Bone Surface 1.6E-08 1.3E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Brain 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Breast 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 GI-Tract Oesophagus 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 St Wall 5.2E-09 2.6E-08 8.6E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 SI Wall 5.5E-09 2.6E-08 8.6E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 ULI Wall 7.7E-09 2.9E-08 9.1E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 LLI Wall 8.0E-09 3.7E-08 1.0E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Colon 7.8E-09 3.3E-08 9.5E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Kidneys 1.1E-07 1.1E-06 3.8E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 Liver 5.9E-08 5.5E-07 2.0E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Muscle 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Ovaries 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Pancreas 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Red Marrow 2.5E-08 2.2E-07 8.0E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Respiratory Tract ET Airways 1.1E-08 3.4E-08 9.5E-08 2.0E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Lungs 6.3E-08 8.3E-08 1.4E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Skin 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Spleen 9.6E-08 9.1E-07 3.3E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 Testes 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Thymus 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Thyroid 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Uterus 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Remainder 5.8E-08 5.4E-07 2.0E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Effective dose 2.0E-08 1.1E-07 3.7E-07 8.5E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.2E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Bladder Wall 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Bone Surface 2.2E-08 1.8E-07 6.5E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Breast 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 GI-Tract Oesophagus 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 St Wall 6.9E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 SI Wall 7.2E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 ULI Wall 8.9E-09 3.8E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 LLI Wall 9.2E-09 4.4E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Colon 9.0E-09 4.1E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Kidneys 1.5E-07 1.4E-06 5.2E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Liver 8.0E-08 7.4E-07 2.7E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 Muscle 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Ovaries 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Pancreas 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Red Marrow 3.4E-08 3.0E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Respiratory Tract ET Airways 1.1E-08 4.1E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Lungs 1.5E-07 1.8E-07 2.6E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Skin 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Spleen 1.3E-07 1.2E-06 4.5E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Testes 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Thymus 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Thyroid 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Uterus 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Remainder 7.9E-08 7.4E-07 2.7E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 Effective dose 3.5E-08 1.6E-07 5.1E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Bladder Wall 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Bone Surface 3.1E-08 2.6E-07 9.3E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Brain 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Breast 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 GI-Tract Oesophagus 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 St Wall 9.6E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 SI Wall 9.7E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 ULI Wall 1.1E-08 5.1E-08 1.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 LLI Wall 1.1E-08 5.5E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Colon 1.1E-08 5.3E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Kidneys 2.2E-07 2.0E-06 7.4E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Liver 1.1E-07 1.1E-06 3.8E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 Muscle 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Ovaries 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Pancreas 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Red Marrow 4.8E-08 4.2E-07 1.5E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Respiratory Tract ET Airways 1.2E-08 5.2E-08 1.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Lungs 2.0E-07 2.4E-07 3.5E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 Skin 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Spleen 1.9E-07 1.8E-06 6.4E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Testes 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Thymus 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Thyroid 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Uterus 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Remainder 1.1E-07 1.0E-06 3.8E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 Effective dose 4.7E-08 2.2E-07 7.2E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.8E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Bladder Wall 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Bone Surface 3.3E-08 2.7E-07 9.7E-07 2.2E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Brain 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Breast 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 GI-Tract Oesophagus 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 St Wall 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 SI Wall 1.0E-08 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 ULI Wall 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 LLI Wall 1.0E-08 5.5E-08 1.8E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Colon 1.0E-08 5.3E-08 1.8E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Kidneys 2.3E-07 2.1E-06 7.7E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Liver 1.2E-07 1.1E-06 4.0E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 Muscle 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Ovaries 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Pancreas 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Red Marrow 5.1E-08 4.4E-07 1.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Respiratory Tract ET Airways 1.1E-08 5.2E-08 1.7E-07 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Lungs 1.1E-07 1.6E-07 2.8E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 Skin 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Spleen 1.9E-07 1.8E-06 6.6E-06 1.5E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Testes 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Thymus 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Thyroid 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Uterus 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Remainder 1.2E-07 1.1E-06 4.0E-06 9.2E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 Effective dose 3.8E-08 2.2E-07 7.4E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 6.4E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bladder Wall 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bone Surface 1.2E-08 9.6E-08 3.4E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 Brain 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Breast 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 GI-Tract Oesophagus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 St Wall 3.6E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 SI Wall 3.8E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 ULI Wall 4.7E-09 2.0E-08 6.4E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 LLI Wall 4.8E-09 2.3E-08 6.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 4.8E-09 2.1E-08 6.6E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Kidneys 8.0E-08 7.6E-07 2.7E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 Liver 4.2E-08 3.9E-07 1.4E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Muscle 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Ovaries 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Pancreas 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Red Marrow 1.8E-08 1.6E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Respiratory Tract ET Airways 5.7E-09 2.1E-08 6.4E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Lungs 2.2E-08 3.6E-08 7.9E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Skin 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Spleen 6.9E-08 6.5E-07 2.4E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 Testes 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thymus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thyroid 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Uterus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Remainder 4.2E-08 3.9E-07 1.4E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Effective dose 1.2E-08 7.5E-08 2.6E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 8.1E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Bladder Wall 4.5E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Bone Surface 1.5E-08 1.2E-07 4.4E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Brain 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Breast 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 GI-Tract Oesophagus 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 St Wall 4.7E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 SI Wall 4.9E-09 2.4E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 ULI Wall 6.6E-09 2.6E-08 8.2E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 6.9E-09 3.2E-08 9.0E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Colon 6.8E-09 2.9E-08 8.5E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Kidneys 1.0E-07 9.6E-07 3.5E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 Liver 5.3E-08 5.0E-07 1.8E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Muscle 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Ovaries 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Pancreas 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Red Marrow 2.3E-08 2.0E-07 7.2E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Respiratory Tract ET Airways 8.5E-09 2.9E-08 8.4E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Lungs 2.5E-08 4.4E-08 9.8E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Skin 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Spleen 8.7E-08 8.3E-07 3.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Testes 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Thymus 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Thyroid 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Uterus 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Remainder 5.3E-08 4.9E-07 1.8E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Effective dose 1.4E-08 9.6E-08 3.3E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 7.9E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bladder Wall 4.3E-09 2.2E-08 7.6E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bone Surface 1.4E-08 1.2E-07 4.2E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 Brain 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Breast 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 GI-Tract Oesophagus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 St Wall 4.6E-09 2.3E-08 7.6E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 SI Wall 4.8E-09 2.3E-08 7.6E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 6.7E-09 2.6E-08 8.0E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 7.0E-09 3.2E-08 8.8E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Colon 6.9E-09 2.9E-08 8.3E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Kidneys 9.8E-08 9.3E-07 3.4E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 Liver 5.2E-08 4.8E-07 1.8E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Muscle 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Ovaries 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Pancreas 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Red Marrow 2.2E-08 1.9E-07 7.0E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Respiratory Tract ET Airways 8.9E-09 2.9E-08 8.2E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Lungs 2.3E-08 4.1E-08 9.4E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Skin 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Spleen 8.5E-08 8.0E-07 2.9E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 Testes 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thymus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thyroid 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Uterus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Remainder 5.1E-08 4.8E-07 1.7E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Effective dose 1.4E-08 9.3E-08 3.2E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 6.7E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bladder Wall 3.7E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bone Surface 1.2E-08 1.0E-07 3.6E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Brain 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Breast 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 GI-Tract Oesophagus 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 St Wall 3.9E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 SI Wall 4.2E-09 2.0E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 ULI Wall 6.0E-09 2.2E-08 6.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 LLI Wall 6.3E-09 2.9E-08 7.6E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Colon 6.2E-09 2.5E-08 7.1E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Kidneys 8.3E-08 7.9E-07 2.9E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 Liver 4.4E-08 4.1E-07 1.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Muscle 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Ovaries 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Pancreas 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Red Marrow 1.9E-08 1.6E-07 5.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Respiratory Tract ET Airways 8.4E-09 2.6E-08 7.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Lungs 1.6E-08 3.1E-08 7.6E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Skin 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Spleen 7.1E-08 6.8E-07 2.5E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 Testes 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thymus 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thyroid 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Uterus 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Remainder 4.3E-08 4.1E-07 1.5E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Effective dose 1.1E-08 7.8E-08 2.7E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 7.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Bladder Wall 1.0E-09 5.8E-09 2.1E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Bone Surface 3.2E-09 3.0E-08 1.2E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Brain 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Breast 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 GI-Tract Oesophagus 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 St Wall 1.6E-09 6.4E-09 2.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 SI Wall 2.3E-09 7.1E-09 2.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 ULI Wall 6.7E-09 1.4E-08 2.9E-08 5.9E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 LLI Wall 7.3E-09 2.9E-08 4.5E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 Colon 7.0E-09 2.0E-08 3.6E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 Kidneys 2.1E-08 2.4E-07 9.2E-07 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Liver 1.1E-08 1.2E-07 4.8E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Ovaries 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Pancreas 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Red Marrow 4.9E-09 5.0E-08 1.9E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Respiratory Tract ET Airways 9.5E-08 6.2E-07 2.3E-06 8.0E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 Lungs 3.5E-06 1.9E-05 5.2E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 Skin 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Spleen 1.8E-08 2.1E-07 7.9E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Testes 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Thymus 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Thyroid 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Uterus 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Remainder 1.4E-09 9.7E-09 3.5E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 Effective dose 4.3E-07 2.2E-06 6.3E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.8E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Bladder Wall 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Bone Surface 3.6E-09 3.5E-08 1.4E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Brain 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Breast 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 GI-Tract Oesophagus 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 St Wall 1.7E-09 7.3E-09 2.6E-08 6.9E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 SI Wall 2.3E-09 8.1E-09 2.7E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 ULI Wall 6.3E-09 1.5E-08 3.4E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 LLI Wall 6.7E-09 3.0E-08 5.1E-08 9.8E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Colon 6.5E-09 2.1E-08 4.2E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Kidneys 2.4E-08 2.8E-07 1.1E-06 3.1E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Liver 1.3E-08 1.4E-07 5.8E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Muscle 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Ovaries 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Pancreas 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Red Marrow 5.5E-09 5.8E-08 2.3E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Respiratory Tract ET Airways 7.6E-08 4.9E-07 1.8E-06 6.4E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Lungs 9.3E-06 4.6E-05 1.3E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 Skin 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Spleen 2.1E-08 2.4E-07 9.7E-07 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Testes 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Thymus 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Thyroid 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Uterus 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Remainder 1.5E-09 1.1E-08 4.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Effective dose 1.1E-06 5.6E-06 1.5E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.4E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bladder Wall 1.2E-09 7.6E-09 3.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bone Surface 4.0E-09 4.0E-08 1.8E-07 6.9E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 Brain 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Breast 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 GI-Tract Oesophagus 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 St Wall 1.6E-09 8.0E-09 3.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 SI Wall 2.0E-09 8.6E-09 3.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 ULI Wall 4.4E-09 1.3E-08 3.9E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 LLI Wall 4.5E-09 2.4E-08 5.3E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 4.5E-09 1.8E-08 4.5E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Kidneys 2.7E-08 3.1E-07 1.4E-06 5.5E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 Liver 1.4E-08 1.6E-07 7.3E-07 2.8E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Muscle 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Ovaries 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Pancreas 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Red Marrow 6.1E-09 6.5E-08 2.9E-07 1.1E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Respiratory Tract ET Airways 3.8E-08 2.5E-07 9.4E-07 3.3E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Lungs 1.2E-05 5.9E-05 1.6E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 Skin 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Spleen 2.3E-08 2.7E-07 1.2E-06 4.7E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 Testes 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thymus 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thyroid 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Uterus 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Remainder 1.7E-09 1.2E-08 5.3E-08 2.0E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Effective dose 1.5E-06 7.1E-06 2.0E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.4E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bladder Wall 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bone Surface 3.7E-09 3.6E-08 1.7E-07 8.6E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Brain 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Breast 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 GI-Tract Oesophagus 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 St Wall 1.3E-09 7.1E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 SI Wall 1.5E-09 7.4E-09 3.2E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 ULI Wall 2.6E-09 9.9E-09 3.5E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 LLI Wall 2.5E-09 1.5E-08 4.4E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Colon 2.5E-09 1.2E-08 3.9E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Kidneys 2.5E-08 2.8E-07 1.4E-06 6.9E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Liver 1.3E-08 1.5E-07 7.1E-07 3.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Muscle 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Ovaries 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Pancreas 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Red Marrow 5.7E-09 5.9E-08 2.9E-07 1.4E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Respiratory Tract ET Airways 1.6E-08 1.0E-07 4.0E-07 1.4E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Lungs 7.0E-06 3.3E-05 9.3E-05 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 Skin 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Spleen 2.2E-08 2.4E-07 1.2E-06 5.9E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Testes 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thymus 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thyroid 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Uterus 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Remainder 1.5E-09 1.1E-08 5.1E-08 2.5E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Effective dose 8.4E-07 4.0E-06 1.1E-05 1.7E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.6E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bladder Wall 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bone Surface 1.8E-09 1.7E-08 7.2E-08 2.7E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Brain 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Breast 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 GI-Tract Oesophagus 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 St Wall 8.1E-10 3.5E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 SI Wall 1.1E-09 3.9E-09 1.3E-08 4.9E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 ULI Wall 2.9E-09 6.7E-09 1.7E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 LLI Wall 3.2E-09 1.3E-08 2.4E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 Colon 3.0E-09 9.4E-09 2.0E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Kidneys 1.2E-08 1.4E-07 5.8E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Liver 6.5E-09 7.1E-08 3.0E-07 1.1E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Ovaries 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Pancreas 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Red Marrow 2.8E-09 2.8E-08 1.2E-07 4.5E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Respiratory Tract ET Airways 4.0E-08 2.6E-07 9.9E-07 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Lungs 1.2E-06 5.9E-06 1.7E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Skin 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Spleen 1.1E-08 1.2E-07 5.0E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Testes 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thymus 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thyroid 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Uterus 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Remainder 7.8E-10 5.4E-09 2.2E-08 8.2E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 Effective dose 1.4E-07 7.1E-07 2.0E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Bladder Wall 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Bone Surface 2.6E-09 2.5E-08 9.9E-08 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Brain 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Breast 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 GI-Tract Oesophagus 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 St Wall 1.3E-09 5.2E-09 1.8E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 SI Wall 1.8E-09 5.8E-09 1.9E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 ULI Wall 5.1E-09 1.1E-08 2.4E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 LLI Wall 5.6E-09 2.2E-08 3.6E-08 7.6E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 Colon 5.3E-09 1.6E-08 2.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Kidneys 1.8E-08 2.0E-07 7.9E-07 2.5E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Liver 9.5E-09 1.0E-07 4.1E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Muscle 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Ovaries 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Pancreas 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Red Marrow 4.1E-09 4.1E-08 1.6E-07 5.2E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 Respiratory Tract ET Airways 7.4E-08 4.8E-07 1.8E-06 6.3E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 Lungs 1.2E-06 5.8E-06 1.6E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Skin 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Spleen 1.5E-08 1.7E-07 6.8E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Testes 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Thymus 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Thyroid 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Uterus 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Remainder 1.1E-09 8.0E-09 3.0E-08 9.6E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Effective dose 1.4E-07 7.1E-07 2.0E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.0E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Bladder Wall 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Bone Surface 2.7E-09 2.6E-08 1.0E-07 2.9E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Brain 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Breast 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 GI-Tract Oesophagus 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 St Wall 1.3E-09 5.4E-09 1.8E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 SI Wall 1.9E-09 6.0E-09 1.9E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 ULI Wall 5.6E-09 1.1E-08 2.5E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 LLI Wall 6.1E-09 2.4E-08 3.8E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 Colon 5.8E-09 1.7E-08 3.0E-08 6.5E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 Kidneys 1.8E-08 2.0E-07 8.0E-07 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Liver 9.7E-09 1.1E-07 4.1E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Ovaries 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Pancreas 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Red Marrow 4.2E-09 4.3E-08 1.6E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Respiratory Tract ET Airways 8.1E-08 5.3E-07 2.0E-06 6.9E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Lungs 9.7E-07 4.6E-06 1.3E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Skin 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Spleen 1.6E-08 1.8E-07 6.9E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Testes 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Thymus 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Thyroid 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Uterus 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Remainder 1.2E-09 8.2E-09 3.1E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 Effective dose 1.2E-07 5.7E-07 1.6E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.0E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Bladder Wall 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Bone Surface 2.5E-09 2.3E-08 8.8E-08 2.3E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Brain 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Breast 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 GI-Tract Oesophagus 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 St Wall 1.2E-09 4.9E-09 1.6E-08 4.1E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 SI Wall 1.8E-09 5.5E-09 1.7E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 ULI Wall 5.4E-09 1.1E-08 2.2E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 LLI Wall 5.9E-09 2.3E-08 3.5E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 Colon 5.6E-09 1.6E-08 2.8E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Kidneys 1.7E-08 1.8E-07 7.0E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Liver 8.8E-09 9.6E-08 3.6E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Muscle 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Ovaries 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Pancreas 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Red Marrow 3.8E-09 3.9E-08 1.5E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Respiratory Tract ET Airways 8.0E-08 5.2E-07 2.0E-06 6.8E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Lungs 5.6E-07 2.5E-06 6.8E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Skin 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Spleen 1.4E-08 1.6E-07 6.1E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Testes 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Thymus 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Thyroid 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Uterus 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Remainder 1.1E-09 7.5E-09 2.7E-08 7.2E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Effective dose 6.9E-08 3.1E-07 8.6E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 9.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Bladder Wall 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Bone Surface 1.8E-10 2.0E-09 7.6E-09 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Brain 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Breast 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 GI-Tract Oesophagus 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 St Wall 6.6E-10 1.0E-09 2.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 SI Wall 1.5E-09 1.9E-09 2.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 ULI Wall 6.6E-09 9.6E-09 1.1E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 LLI Wall 7.2E-09 2.7E-08 2.9E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 Colon 6.9E-09 1.7E-08 1.9E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 Kidneys 1.2E-09 1.6E-08 6.0E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Liver 6.5E-10 8.1E-09 3.1E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 Muscle 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Ovaries 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Pancreas 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Red Marrow 2.8E-10 3.3E-09 1.2E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 Respiratory Tract ET Airways 1.0E-07 6.9E-07 2.7E-06 1.5E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Lungs 3.9E-06 2.1E-05 6.1E-05 9.5E-05 9.5E-05 9.5E-05 9.5E-05 9.5E-05 9.5E-05 9.5E-05 Skin 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Spleen 1.1E-09 1.3E-08 5.2E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Testes 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Thymus 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Thyroid 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Uterus 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Remainder 1.6E-10 9.8E-10 3.6E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 Effective dose 4.7E-07 2.5E-06 7.3E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Bladder Wall 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Bone Surface 1.7E-10 2.0E-09 8.1E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Brain 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Breast 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 GI-Tract Oesophagus 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 St Wall 6.3E-10 1.0E-09 2.1E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 SI Wall 1.5E-09 1.9E-09 3.1E-09 5.8E-09 5.8E-09 5.8E-09 5.8E-09 5.8E-09 5.8E-09 5.8E-09 ULI Wall 6.0E-09 9.6E-09 1.2E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 LLI Wall 6.4E-09 2.7E-08 3.1E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Colon 6.2E-09 1.7E-08 2.0E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 Kidneys 1.1E-09 1.6E-08 6.5E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Liver 6.0E-10 8.2E-09 3.3E-08 9.4E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Muscle 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Ovaries 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Pancreas 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Red Marrow 2.6E-10 3.3E-09 1.3E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 Respiratory Tract ET Airways 8.3E-08 5.5E-07 2.2E-06 1.2E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Lungs 1.0E-05 5.2E-05 1.5E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 Skin 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Spleen 9.8E-10 1.4E-08 5.6E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Testes 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Thymus 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Thyroid 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Uterus 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Remainder 1.4E-10 9.1E-10 3.5E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Effective dose 1.2E-06 6.2E-06 1.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.0E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Bladder Wall 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Bone Surface 1.2E-10 1.6E-09 7.3E-09 3.0E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 Brain 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Breast 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 GI-Tract Oesophagus 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 St Wall 4.3E-10 7.7E-10 1.9E-09 6.0E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 SI Wall 9.6E-10 1.4E-09 2.7E-09 7.0E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 ULI Wall 3.7E-09 7.1E-09 9.8E-09 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 LLI Wall 3.7E-09 2.0E-08 2.6E-08 3.5E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Colon 3.7E-09 1.3E-08 1.7E-08 2.4E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Kidneys 7.9E-10 1.3E-08 5.8E-08 2.4E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Liver 4.2E-10 6.5E-09 3.0E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Muscle 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Ovaries 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Pancreas 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Red Marrow 1.8E-10 2.6E-09 1.2E-08 5.0E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Respiratory Tract ET Airways 4.1E-08 2.7E-07 1.1E-06 5.8E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Lungs 1.4E-05 6.6E-05 1.9E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 Skin 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Spleen 6.9E-10 1.1E-08 5.0E-08 2.1E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Testes 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Thymus 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Thyroid 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Uterus 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Remainder 9.1E-11 6.5E-10 2.7E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Effective dose 1.6E-06 8.0E-06 2.3E-05 3.6E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.9E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Bladder Wall 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Bone Surface 7.2E-11 9.7E-10 5.2E-09 3.3E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Brain 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Breast 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 GI-Tract Oesophagus 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 St Wall 2.0E-10 4.2E-10 1.3E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 SI Wall 4.5E-10 7.7E-10 1.8E-09 6.9E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 ULI Wall 1.7E-09 3.7E-09 6.0E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 LLI Wall 1.6E-09 1.0E-08 1.5E-08 2.7E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 Colon 1.7E-09 6.4E-09 1.0E-08 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Kidneys 4.8E-10 7.6E-09 4.1E-08 2.6E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Liver 2.6E-10 3.9E-09 2.1E-08 1.4E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Muscle 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Ovaries 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Pancreas 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Red Marrow 1.1E-10 1.6E-09 8.6E-09 5.4E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 Respiratory Tract ET Airways 1.7E-08 1.1E-07 4.4E-07 2.3E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Lungs 7.7E-06 3.8E-05 1.1E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 Skin 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Spleen 4.2E-10 6.6E-09 3.6E-08 2.3E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Testes 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Thymus 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Thyroid 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Uterus 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Remainder 4.8E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Effective dose 9.3E-07 4.5E-06 1.3E-05 2.2E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Bladder Wall 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Bone Surface 8.1E-11 8.8E-10 3.6E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 Brain 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Breast 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 GI-Tract Oesophagus 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 St Wall 2.8E-10 4.3E-10 9.2E-10 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 SI Wall 6.4E-10 8.1E-10 1.3E-09 3.1E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 ULI Wall 2.7E-09 4.0E-09 4.8E-09 7.0E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 LLI Wall 3.0E-09 1.1E-08 1.3E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 Colon 2.9E-09 7.2E-09 8.3E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Kidneys 5.4E-10 6.9E-09 2.9E-08 1.0E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Liver 2.9E-10 3.6E-09 1.5E-08 5.4E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Muscle 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Ovaries 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Pancreas 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Red Marrow 1.2E-10 1.4E-09 5.9E-09 2.2E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Respiratory Tract ET Airways 4.4E-08 2.9E-07 1.2E-06 6.2E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 Lungs 1.3E-06 6.6E-06 1.9E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Skin 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Spleen 4.7E-10 6.0E-09 2.5E-08 9.0E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 Testes 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Thymus 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Thyroid 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Uterus 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Remainder 6.9E-11 4.3E-10 1.6E-09 6.9E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 Effective dose 1.6E-07 8.0E-07 2.3E-06 4.2E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.4E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Bladder Wall 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Bone Surface 1.4E-10 1.5E-09 5.8E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Brain 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Breast 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 GI-Tract Oesophagus 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 St Wall 5.0E-10 7.5E-10 1.5E-09 3.5E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 SI Wall 1.2E-09 1.4E-09 2.2E-09 4.3E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 ULI Wall 5.0E-09 7.1E-09 8.2E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 LLI Wall 5.4E-09 2.0E-08 2.2E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Colon 5.2E-09 1.3E-08 1.4E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Kidneys 9.4E-10 1.2E-08 4.7E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Liver 5.0E-10 6.1E-09 2.4E-08 7.2E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 Muscle 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Ovaries 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Pancreas 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Red Marrow 2.1E-10 2.5E-09 9.6E-09 2.9E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 Respiratory Tract ET Airways 8.1E-08 5.4E-07 2.1E-06 1.1E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Lungs 1.3E-06 6.5E-06 1.9E-05 3.3E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 Skin 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Spleen 8.1E-10 1.0E-08 4.0E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Testes 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Thymus 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Thyroid 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Uterus 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Remainder 1.2E-10 7.5E-10 2.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Effective dose 1.6E-07 7.8E-07 2.3E-06 4.0E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.7E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Bladder Wall 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Bone Surface 1.5E-10 1.6E-09 6.2E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Brain 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Breast 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 GI-Tract Oesophagus 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 St Wall 5.4E-10 8.1E-10 1.6E-09 3.5E-09 3.6E-09 3.6E-09 3.6E-09 3.6E-09 3.6E-09 3.6E-09 SI Wall 1.3E-09 1.5E-09 2.4E-09 4.3E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 ULI Wall 5.5E-09 7.8E-09 8.8E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 LLI Wall 6.0E-09 2.2E-08 2.4E-08 2.6E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Colon 5.7E-09 1.4E-08 1.5E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Kidneys 1.0E-09 1.3E-08 5.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Liver 5.4E-10 6.6E-09 2.6E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Muscle 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Ovaries 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Pancreas 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Red Marrow 2.3E-10 2.7E-09 1.0E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 Respiratory Tract ET Airways 8.9E-08 5.9E-07 2.4E-06 1.3E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Lungs 1.1E-06 5.2E-06 1.5E-05 2.6E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Skin 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Spleen 8.8E-10 1.1E-08 4.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Testes 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Thymus 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Thyroid 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Uterus 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Remainder 1.3E-10 8.1E-10 3.0E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Effective dose 1.3E-07 6.3E-07 1.8E-06 3.1E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type S, f1 = 0.01 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Bladder Wall 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Bone Surface 1.5E-10 1.6E-09 5.9E-09 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 Brain 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Breast 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 GI-Tract Oesophagus 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 St Wall 5.3E-10 7.8E-10 1.5E-09 3.1E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 SI Wall 1.2E-09 1.5E-09 2.3E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 ULI Wall 5.4E-09 7.6E-09 8.4E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 LLI Wall 5.9E-09 2.1E-08 2.3E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Colon 5.6E-09 1.4E-08 1.5E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 Kidneys 9.8E-10 1.2E-08 4.7E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Liver 5.2E-10 6.4E-09 2.4E-08 6.2E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Muscle 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Ovaries 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Pancreas 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Red Marrow 2.3E-10 2.6E-09 9.7E-09 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Respiratory Tract ET Airways 8.8E-08 5.9E-07 2.3E-06 1.2E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Lungs 6.2E-07 2.8E-06 7.9E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Skin 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Spleen 8.5E-10 1.1E-08 4.0E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Testes 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Thymus 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Thyroid 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Uterus 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Remainder 1.3E-10 7.9E-10 2.9E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Effective dose 7.5E-08 3.4E-07 9.6E-07 1.6E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06